The healthcare automation technology provider received $32.8m in a round featuring Ascension Ventures, boosting its equity funding to $68m in total.
Olive, a US-based developer of automation technology for the healthcare sector, has raised $32.8m in series D funding from investors including Ascension Ventures, the venture capital firm formed by healthcare provider Ascension.
Growth equity fund Oak HC/FT also contributed to the round along with existing investors including Drive Capital and SVB Capital. John Kuelper, an investment director at Ascension Ventures, will join Olive’s board of directors together with Oak HC/FT principal Billy Deitch.
Founded as CrossChx, Olive produces artificial intelligence…
